menu
    • menu

    Company profile for IRLAB

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Share this: We are dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). We strive to improve the future for patients who, today, lack effective treatment options. Research and development within CNS What distinguishes IRLAB’s research and development activities is, in particular, our unique proprieta...
    Share this: We are dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). We strive to improve the future for patients who, today, lack effective treatment options. Research and development within CNS What distinguishes IRLAB’s research and development activities is, in particular, our unique proprietary research platform ISP – Integrative Screening Process. The platform enables discovery and development of therapeutic candidates for diseases related to the central nervous system (CNS).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IRLABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Arvid Wallgrens Backe 20 413 46 Gothenburg, Sweden
    Telephone
    Telephone
    +46(0)31 757 38 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://irlab.se/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/irlab-therapeutics-ab/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/IRLABThera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Receives Milestone Payment For Phase Ib Study
    IRLAB Receives Milestone Payment For Phase Ib Study

    26 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-26/irlab-secures-milestone-payment-for-first-patient-dosed-in-phase-ib-study-with-irl757-in-parkinsons

    PHARMIWEB
    26 Feb 2026
    Share Share
    IRLAB: Invites To 2025 Year-End Report Presentation
    IRLAB: Invites To 2025 Year-End Report Presentation

    18 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-18/irlab-invitation-to-the-year-end-report-2025-presentation-and-webcast

    PHARMIWEB
    18 Feb 2026
    Share Share
    IRLAB, Biomia ApS Collaborate on ISP App
    IRLAB, Biomia ApS Collaborate on ISP App

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/irlab-enters-collaboration-agreement-with-danish-biotech-company-biomia-aps-applying-the-integrative

    PHARMIWEB
    19 Jan 2026
    Share Share
    IRLAB Greenlit For IRL757 Phase Ib Study In Parkinson's Disease
    IRLAB Greenlit For IRL757 Phase Ib Study In Parkinson's Disease

    23 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-23/irlab-receives-approval-for-a-phase-ib-study-with-irl757-in-parkinsons-disease

    PHARMIWEB
    23 Dec 2025
    Share Share
    IRLAB Joins Redeye Tech & Life Science Day 2025
    IRLAB Joins Redeye Tech & Life Science Day 2025

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/irlab-participates-in-redeye-technology-life-science-day-on-december-3-2025

    PHARMIWEB
    27 Nov 2025
    Share Share
    Irlab Appoints Nomination Committee For 2026 Agm
    Irlab Appoints Nomination Committee For 2026 Agm

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/nomination-committee-appointed-for-irlabs-annual-general-meeting-2026

    PHARMIWEB
    20 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search